ALNYLAM PHARMACEUTICALS, INC. Interest Expense 2008-2024 | ALNY
Beta
What is interest expense?
Interest expense represents the cost of borrowing money, including interest paid on bonds, loans, and other debt obligations.
What is ALNYLAM PHARMACEUTICALS, INC.'s current interest expense?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual interest expense for 2023 was $121.2M, a 22.28% decline from 2022. ALNYLAM PHARMACEUTICALS, INC. interest expense for the quarter ending March 31, 2024 was $35.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s interest expense in 2022?
ALNYLAM PHARMACEUTICALS, INC. annual interest expense for 2022 was $156.0M, a 9.05% increase from 2021.
What was ALNYLAM PHARMACEUTICALS, INC.'s interest expense in 2021?
ALNYLAM PHARMACEUTICALS, INC. annual interest expense for 2021 was $143.0M, a 69.26% increase from 2020.
Interest Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2018
$0
→
FY2023
$121.2M
08181920212223
5 years selected
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →